Researchers could be closing in on a “fountain of youth” drug that can delay the effects of aging and improve the health of older adults, a new study suggests
Seniors received a significant boost to their immune systems when given a drug that targets a genetic signaling pathway linked to aging and immune function, researchers with the drug maker Novartis report.
The experimental medication, a version of the drug rapamycin, improved the seniors’ immune response to a flu vaccine by 20 percent, researchers said in the current issue of Science Translational Medicine.
The study is a “watershed” moment for research into the health effects of aging, said Dr. Nir Barzilai, director of the Institute for Aging Research at Albert Einstein College of Medicine in New York City.
Rapamycin belongs to a class of drugs known as mTOR inhibitors, which have been shown to counteract aging and aging-related diseases in mice and other animals.
Barzilai, who wasn’t involved in the study, said this is one of the first studies to show that these drugs also can delay the effects of aging in humans.
“It sets the stage for using this drug to target aging, to improve everything about aging,” Barzilai said. “That’s really going to be for us a turning point in research, and we are very excited.”
The mTOR genetic pathway promotes healthy growth in the young. But it appears to have a negative effect on mammals as they grow older, said study lead author Dr. Joan Mannick, executive director of the New Indications Discovery Unit at the Novartis Institutes for Biomedical Research.
When drugs like rapamycin are used to inhibit the effects of the mTOR pathway in mice, they “seem to extend lifespan and delay the onset of aging-related illnesses,” Mannick said.
Mannick and her colleagues decided to investigate whether a rapamycin-like drug could reverse the natural decline that elderly people experience in their ability to fight off infections.
In the clinical trial, more than 200 people age 65 and older randomly received either the experimental drug or a placebo for several weeks, followed by a dose of flu vaccine.
Flu is particularly hard on seniors, with people 65 and older accounting for nine out of 10 influenza-related deaths in the United States, according to background information provided by the researchers.
Those who received the experimental version of rapamycin developed about 20 percent more antibodies in response to the flu vaccine, researchers found. Even low doses of the medication produced an improved immune response.
The researchers also found that the group given the drug generally had fewer white blood cells associated with age-related immune decline.
Mannick called this study the “first baby step,” and was reluctant to say whether it could lead to immune-boosting medications for the elderly.
Read more: Researchers take ‘first baby step’ toward anti-aging drug
The Latest on: Anti-aging drug
[google_news title=”” keyword=”Anti-aging drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Anti-aging drug
- Why do some researchers believe metformin may hold the key to longevity?on May 7, 2024 at 3:30 am
Some researchers are investigating how metformin, a common drug used to treat diabetes, may help prolong healthspan and lifespan. What evidence is there to support this notion?
- Association of inflammatory and metabolic biomarkers and accelerated aging in cardiac catheterization patientson May 6, 2024 at 4:59 pm
A new research paper was published in Aging, entitled, “Associations among NMR-measured inflammatory and metabolic biomarkers and accelerated aging in cardiac catheterization patients.” ...
- Announcing Aging as Tier 5 Sponsor of ARDD 2024on May 5, 2024 at 5:00 pm
The University of Copenhagen is excited to announce Aging as a Tier 5 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the ...
- Anti-aging doc says little-known peptide may be better than retinol & vitamin C – & warns against ‘overpriced’ skincareon May 2, 2024 at 6:31 am
AN effective skincare routine doesn’t have to cost you an arm and a leg. A physician revealed the anti-aging ingredient that may work better than retinol. Dr. Michael Aziz spoke exclusively ...
- High blood pressure drug called 'rilmenidine' dramatically slows aging in animalson May 1, 2024 at 2:41 pm
A drug used for high blood pressure, known as rilmenidine, may also be effective in slowing the aging process.
- New Technique to Identify Anti-Aging Moleculeson April 30, 2024 at 1:11 pm
As the human body ages, cellular changes can drive a host of age-related diseases and conditions. The appearance of aging cells, also called senescent cells, in age-related diseases has spurred the ...
- How cheap, generic drug became a darling of longevity enthusiastson April 27, 2024 at 5:00 pm
The drug is going mainstream as an anti-aging treatment, even though rapamycin’s regulatory approval is for treating transplant patients. There is no evidence that it can extend human life.
- Best anti-aging eye creams to help you turn back the clockon April 26, 2024 at 8:57 pm
Our guide to the best anti-aging eye creams will help you to rejuvenate the skin around your eyes and reduce the signs of aging, with clinically proven results.
- Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicineon April 25, 2024 at 9:07 am
Liu Yanhong, Deputy Director of Hebei Provincial Administration of Traditional Chinese Medicine, remarked that anti-aging is an eternal topic in human health and currently one of the hottest research ...
- Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicineon April 25, 2024 at 1:07 am
On April 21, the 3rd Traditional Chinese Medicine Anti-Aging Conference, hosted by the World Federation of Chinese Medicine Societies, was held in Shijiazhuang. Yiling Pharmaceutical's Bazi Bushen ...
via Bing News